In addition, the distinct gene expression profiles of immature AML cells as determined by scRNA-seq were found to align better with the underlying genetic subtype than the bulk expression profiles for AMLs with NPM1 mutations and the fusion genes CBFB::MYH11 and RUNX1::RUNX1T1. This evidence concerns the gene RUNX1 and acute myeloid leukemia.